11-15 April 2018
EASL International Liver Congress & the Liver Forum
Paris, France
The European Association for the Study of the Liver (EASL) is an organisation founded during 1966. This year EASL expects a congress attendance of up to 11,000 delegates and over 250 media representatives from all across the globe.
These delegates include various scientific and medical experts interested in liver research and working in the fields of hepatology, gastroenterology, internal medicine, cell biology, transplant surgery, infectious diseases, microbiology and virology, pharmacology, pathology and radiology.
The EASL International Liver Congress and the associated Liver Forum (held on the 10th) will be attended by both our Chief Scientific Officer, Professor Tim St Pierre, and our Clinical Research Manager, Dr Sherif Boulos. They will be coordinating high level clinical discussions with experts, potential collaborators, and KOL’s in the liver community on current, future pipeline, and clinical trial services for HepaFat-Scan, FerriScan and our newly-developed NASH-related technologies.
Professor Tim St Pierre will be presenting new data at the EASL congress.
We would welcome the opportunity to meet with you all during the EASL International Liver Congress. To organise a meeting with us please contact sherifb@resonancehealth.com with your preferred date and time availability.
For more information on the conference please click here…